News Digest / Ticker: VCEL

Ticker: VCEL

09:01am, Thursday, Jul 31, 2025

Vericel Corporation Sees 20.1% Revenue Growth and Narrowing Losses in Q2 2025 Financials

Company Overview Vericel Corporation (NASDAQ: VCEL) is a biopharmaceutical company based in Michigan that specializes in advanced therapies for sports medicine and severe burn care. Their portfolio includes MACI®, Epicel®, and NexoBrid®. Q2 2025 Financial Highlights Total Revenue: Increased to $...

09:00am, Thursday, May 08, 2025

Vericel Reports Q1 2025 Results: Revenue Up but Net Losses Widen Amid Rising Expenses